Sunrest Lifescience Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|
| Revenue | 6.84 | 5.64 | 6.87 |
| Operating Expense | 6.19 | 4.63 | 7.16 |
| Net Profit | 1.23 | 0.75 | -0.32 |
| Net Profit Margin | 17.98 | 13.30 | -4.66 |
| Earning Per Share | 4.12 | 2.50 | TBA |
| EBIDTA | 0.65 | 1 | -0.27 |
| Effective Tax Rate | -93.85 | 22 | 7.14 |
| Particulars | Sep 2023 |
|---|---|
| Revenue | 6.84 |
| Operating Expense | 6.19 |
| Net Profit | 1.23 |
| Net Profit Margin | 17.98 |
| Earning Per Share | 4.12 |
| EBIDTA | 0.65 |
| Effective Tax Rate | -93.85 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 33.12 | 29.48 | 24.64 |
| Operating Expenses Annual | 30.12 | 28.58 | 21.74 |
| Operating Profit Annual | 3.00 | 0.91 | 2.93 |
| Interest Annual | 0.30 | 0.22 | 0.06 |
| Depreciation | 0.09 | 0.09 | 0.13 |
| Net Profit Annual | 2.00 | 0.23 | 2.04 |
| Tax Annual | 0.61 | 0.37 | 0.70 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 33.12 |
| Operating Expenses Annual | 30.12 |
| Operating Profit Annual | 3.00 |
| Interest Annual | 0.30 |
| Depreciation | 0.09 |
| Net Profit Annual | 2.00 |
| Tax Annual | 0.61 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 0.29 | 0.45 | 0.48 |
| Cash Flow from Operations | 1.43 | -14.80 | 1.15 |
| Cash Flow from Investing | -1.14 | -0.01 | -0.03 |
| Cash Flow from Financing | -0.30 | 14.64 | -1.15 |
| Cash Flow at the End | 0.28 | 0.29 | 0.45 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 0.29 |
| Cash Flow from Operations | 1.43 |
| Cash Flow from Investing | -1.14 |
| Cash Flow from Financing | -0.30 |
| Cash Flow at the End | 0.28 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 9.06 | 3.09 | 11.89 |
| PBIT Margin (%) | 8.79 | 2.75 | 11.36 |
| PBT Margin (%) | -20.50 | -9.90 | -178.05 |
| Net PROFIT Margin (%) | 6.04 | 0.78 | 8.28 |
| Return On Networth / Equity (%) | 13.18 | 2.66 | 97.61 |
| Return On Networth /Employed (%) | 13.53 | 6.41 | 58.58 |
| Return On Assets (%) | 9.30 | 1.79 | 42.64 |
| Total Debt / Equity (X) | 0.41 | 0.48 | 1.29 |
| Asset Turnover Ratio (%) | 1.54 | 2.30 | 5.15 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 9.06 |
| PBIT Margin (%) | 8.79 |
| PBT Margin (%) | -20.50 |
| Net PROFIT Margin (%) | 6.04 |
| Return On Networth / Equity (%) | 13.18 |
| Return On Networth /Employed (%) | 13.53 |
| Return On Assets (%) | 9.30 |
| Total Debt / Equity (X) | 0.41 |
| Asset Turnover Ratio (%) | 1.54 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 1.32 | 0.26 | 0.35 |
| Total Current Assets Annual | 28.26 | 24.83 | 16.30 |
| Non Current Assets Annual | 6.89 | 0.32 | 0.41 |
| Total Shareholders Funds Annual | 16.19 | 14.19 | 3.11 |
| Total Assets Annual | 35.16 | 25.16 | 16.71 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 1.32 |
| Total Current Assets Annual | 28.26 |
| Non Current Assets Annual | 6.89 |
| Total Shareholders Funds Annual | 16.19 |
| Total Assets Annual | 35.16 |
No Data Availabe
